For weight management, NICE has appraised several licensed medicines that are available through NHS pathways or regulated private clinics: Semaglutide (Wegovy) NICE Technology Appraisal TA875 recommends semaglutide as an option for managing overweight and obesity in adults with a BMI of 35 kg/m or more (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when used within a specialist weight management service
BPC-157 is a recovery peptide with a genuinely interesting repair mechanism, but the result you get depends far less on the molecule and far more on the source, the dose, and the provider behind it
Find out who is eligible to get these shots and when, and learn who can still get the original boosters, in our updated CL Answer about COVID-19 vaccines
They have awesome massage chairs too
These resources eliminate calculation errors that could compromise weight loss results
5-Amino-1MQ injection should be administered subcutaneously (under the skin) using a 29-31 gauge insulin syringe